Redeye publishes its financial forecast for Orexo. It is important that the company keeps up innovation and new product development in the pharma segment, in our view, and we expect the company to return to profitability in 2024.
ANNONS
Redeye publishes its financial forecast for Orexo. It is important that the company keeps up innovation and new product development in the pharma segment, in our view, and we expect the company to return to profitability in 2024.